GAG therapy
Showing 1 - 25 of >10,000
Recurrent Urinary Tract Infection Trial in Nijmegen (Ialuril 50ml Prefill, Nitrofurantoin)
Recruiting
- Recurrent Urinary Tract Infection
- Ialuril 50ml Prefill
- Nitrofurantoin
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Dec 14, 2022
Spinal Cord Injuries Trial in Perth (iAluRil® intravesical instillations)
Completed
- Spinal Cord Injuries
- iAluRil® intravesical instillations
-
Perth, Western Australia, AustraliaRoyal Perth Hospital
Apr 30, 2021
HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)
Completed
- HIV-1-infection
- PENNVAX-GP
- +3 more
-
Los Angeles, California
- +1 more
Apr 4, 2022
HIV Trial in American Samoa, Australia, United States (MRKAd5 HIV-1 gag/pol/nef, MRKAd5 HIV-1 gag/pol/nef )
Completed
- HIV Infections
- MRKAd5 HIV-1 gag/pol/nef
- MRKAd5 HIV-1 gag/pol/nef placebo
-
San Diego, California
- +22 more
Oct 28, 2021
HIV Trial in Philadelphia (WT-gag-TCR modified T cells, a/6-gag-TCR modified T cells, STI or Drug Holiday)
Completed
- HIV Infections
- WT-gag-TCR modified T cells
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 9, 2019
HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Worldwide (palbociclib, trastuzumab, pertuzumab)
Active, not recruiting
- HER-2 Positive Breast Cancer
- Estrogen Receptor Positive Breast Cancer
- palbociclib
- +6 more
-
San Francisco, California
- +106 more
Mar 16, 2022
Recurrent Urinary Tract Infection Trial in Basingstoke (Rigid cystoscopy with urethral dilatation, Flexible cystoscopy and
Withdrawn
- Recurrent Urinary Tract Infection
- Rigid cystoscopy with urethral dilatation
- Flexible cystoscopy and installation of Glycosaminoglycan layer replacement (laluril)
-
Basingstoke, Hampshire, United KingdomHampshire Hospitals NHS Foundation Trust
Sep 21, 2021
Respiratory Cathepsins, Proteases Inhibitors and
Completed
- Mucopolysaccharidoses
- Sputum
- Tracheal aspiration
-
Angers, France
- +6 more
Jan 3, 2022
Mucopolysaccharidosis II Trial in Salt Lake City, Fairfax (Genetic HMI-203)
Recruiting
- Mucopolysaccharidosis II
- Genetic HMI-203
-
Oakland, California
- +5 more
Jan 26, 2023
MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))
Withdrawn
- MPS I
- +2 more
- SIG-005 (hIDUA Producing Spheres)
-
Porto Alegre, Brazil
- +2 more
Dec 16, 2022
HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)
Not yet recruiting
- HIV-1-infection
- VRC07-523LS
- +7 more
-
Pathum Wan, Bangkok, Thailand
- +1 more
Mar 8, 2023
HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))
Enrolling by invitation
- HIV
- Antiretroviral Therapy Interruption(ATI)
-
Washington, District of Columbia
- +1 more
Sep 12, 2022
Mucopolysaccharidosis II Trial in Cincinnati (DNL310)
Enrolling by invitation
- Mucopolysaccharidosis II
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 10, 2023
MPS I Trial in Oakland (SB-318)
Terminated
- MPS I
- SB-318
-
Oakland, CaliforniaUCSF Benioff Children's Hospital Oakland
Jan 6, 2023
HIV I Infection Trial in Melbourne (Nivolumab 10 MG/ML [Opdivo], Saline)
Not yet recruiting
- HIV I Infection
- Nivolumab 10 MG/ML [Opdivo]
- Saline
-
Melbourne, Victoria, AustraliaAlfred Hospital - Department of Infecious Diseases
May 16, 2022
Examinations for Asymptomatic MPS I Infants in Taiwan
Recruiting
- MPS I
- MPS I
-
Taipei, TaiwanMackay Memorial Hospital
Mar 2, 2022
Mucopolysaccharidosis Type II (MPS II) Trial in Brazil, United States (RGX-121)
Recruiting
- Mucopolysaccharidosis Type II (MPS II)
- RGX-121
-
Oakland, California
- +4 more
Dec 22, 2022
Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome Trial in Winston-Salem (Pulsed Electromagnetic Field
Not yet recruiting
- Interstitial Cystitis
- +2 more
- Pulsed Electromagnetic Field (PEMF) Device
- Sham Pulsed Electromagnetic Feild (PEMF) Device
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Aug 22, 2023
HIV/AIDS Trial in San Francisco (Combination Intervention)
Active, not recruiting
- HIV/AIDS
- Combination Intervention
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital, University of Califor
Mar 21, 2022
Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)
Not yet recruiting
- Mucopolysaccharidosis II
- Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
- (no location specified)
Dec 16, 2022
Gag-layer in the Urothelium of the Human Upper Urinary Tract
Recruiting
- Bladder Cancer
- Renal Cancer
- Chondroitin Sulfate Staining
-
Aarhus, DenmarkAarhus University Hospital
May 30, 2022
Mucopolysaccharidosis Type VI Trial in Naples, Ankara (AAV2/8.TBG.hARSB)
Active, not recruiting
- Mucopolysaccharidosis Type VI
- AAV2/8.TBG.hARSB
-
Naples, Italy
- +1 more
Nov 22, 2021
Mucopolysaccharidosis Trial in Gaziantep (Enzyme Replacement Agent)
Completed
- Mucopolysaccharidosis
- Enzyme Replacement Agent
-
Gaziantep, None Selected, TurkeySerkan Usgu
Aug 7, 2021
Premature; Infant, Light-for-dates, Neonatal Disease, Neurodevelopmental Disorders Trial in Samsun (Physiotherapy application,
Completed
- Premature; Infant, Light-for-dates
- +3 more
- Physiotherapy application
- Control Group
-
Samsun, Atakum, TurkeyNilay Çömük Balci
May 8, 2023